test

Marc Larkins

@Johnson & Johnson

Latest period2024 - Q3ReportedManaged Assets$427.326MTotal holdings20
Assets growth rate6.66%Assets growth rate (2-Q avg)-42.13%Continuous growth in asset value1 quarters

Portfolio positions

This chart displays the top 10 holdings in Johnson & Johnson's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 20 positions.

Assets under management

The assets under management (AUM) of Johnson & Johnson over the past 10 years (40 quarters) show continuous growth in total asset value over the last 1 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 427.326M in assets, with a quarterly growth rate of 6.66% and a 2-quarter average growth rate of -42.13%. The portfolio is managed by Marc Larkins, and others.

Portfolio holdings

CurrentNew PositionIncreasedDecreasedExited
InvestmentPortfolio %Reported Value
PTGXProtagonist Therapeutics Inc.
Recent Activity
25.8%
$110.213M
2.449M shares@ $45.0 avg price
RAPPRapport Therapeutics, Inc.
Recent Activity
11.98%
$51.16M
2.498M shares@ $20.48 avg price
LEGNLegend Biotech Corporation
Recent Activity
9.29%
$39.695M
814,586 shares@ $48.74 avg price
CTNMContineum Therapeutics Inc.
Recent Activity
8.87%
$37.881M
1.979M shares@ $19.14 avg price
CVRXCvrx, Inc.
Recent Activity
8.46%
$36.151M
4.103M shares@ $8.81 avg price
NBTXNanobiotix S.a.
Recent Activity
7.57%
$32.337M
5.624M shares@ $5.75 avg price
PRCTProcept Biorobotics Corporation
Recent Activity
6.72%
$28.678M
357,939 shares@ $80.13 avg price
MGTXMeiragtx Holdings Plc
Recent Activity
6.49%
$27.693M
6.641M shares@ $4.18 avg price
NMRANeumora Therapeutics, Inc.
Recent Activity
5.72%
$24.431M
1.849M shares@ $13.21 avg price
XNCRXencor, Inc.
Recent Activity
3.53%
$15.044M
748,062 shares@ $20.12 avg price